Prognostic value of <i>GPC5</i> polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients

Fan Wang,Yutao Li,Zhengxing Li,Zixiu Zou,Yongming Lu,Chang Xu,ZongXu Zhao,HuaiZhou Wang,Yi Wang,Shicheng Guo,Li Jin,Jiucun Wang,Qiang Li,GengXi Jiang,Fan Xia,Bo Shen,Junjie Wu
DOI: https://doi.org/10.2217/fon-2022-0319
2022-01-01
Future Oncology
Abstract:Background: GPC5 rs2352028 is associated with the risk of lung cancer, but its relationship with lung cancer prognosis is unclear. Materials & methods: The authors collected blood samples from 888 patients with lung cancer and used a Cox proportional hazards model to analyze the association between prognosis and GPC5 polymorphism rs2352028. Results: GPC5 rs2352028 C > T was associated with a better prognosis. Patients with CT genotype had longer overall survival than those with CC genotype. Additionally, older and early-stage patients with CT + TT genotype had a lower risk of death than those with CC genotype. Conclusion: GPC5 rs2352028 C > T may play a protective role in patients with lung cancer and GPC5 rs2352028 may be a potential genetic marker for lung cancer prognosis.
What problem does this paper attempt to address?